Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

876
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
876

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations of Physical Activity With Mortality Across Cardiovascular-Kidney-Metabolic Syndrome Stages: Evidence From NHANES 1999 to 2018.

Journal of the American Heart Association·2026
Same author

Prognostic significance of therapy-induced senescence and SASP dynamics in acute myeloid leukemia: a retrospective cohort study.

BMC cancer·2026
Same author

Small peptide encoded by MALAT1 aggravates colitis via upregulating GIP expression in enterocyte.

Biochemical pharmacology·2026
Same author

Study on the Optimization of Mix Proportions for Recycled Aggregate Concrete and Its Freeze-Thaw Resistance Performance.

Materials (Basel, Switzerland)·2026
Same author

Bispecific targeting of CHI3L1 and PD-1 as a therapeutic strategy for pulmonary fibrosis.

JCI insight·2026
Same author

Review of the biological gap between mother's own milk and pasteurized donor milk: implications for intestinal health in preterm infants.

Pediatric research·2026

Related Experiment Video

Updated: Nov 23, 2025

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.7K

Peptide-Based Nanomaterials for Tumor Immunotherapy.

Lingyun Li1, Bing Ma1, Weizhi Wang1

  • 1School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing 100081, China.

Molecules (Basel, Switzerland)
|January 5, 2021
PubMed
Summary
This summary is machine-generated.

Peptide-based nanomaterials offer promising advancements in tumor immunotherapy by enhancing drug delivery and enabling combination therapies. New peptide screening methods, including machine learning, are crucial for developing these targeted cancer treatments.

Keywords:
immune checkpoint blockadepeptide screeningpeptide self-assemblypeptide-based nanomaterials

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.9K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.0K

Related Experiment Videos

Last Updated: Nov 23, 2025

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.7K
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.9K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.0K

Area of Science:

  • Oncology
  • Immunology
  • Materials Science
  • Biotechnology

Background:

  • Tumor immunotherapy, particularly immune checkpoint blockade, is a rapidly advancing field requiring more effective and safer drugs.
  • Peptides are emerging as valuable theranostic reagents due to their biocompatibility, targeting capabilities, and specificity.
  • Nanomaterials offer advantages as drug carriers, improving drug affinity and enabling combination therapies for cancer treatment.

Purpose of the Study:

  • To review the development of peptide-based nanomaterials for tumor immunotherapy.
  • To highlight functionalization and self-assembly strategies for these nanomaterials.
  • To discuss advanced peptide screening methods, including machine learning, for platform development.

Main Methods:

  • Review of current literature on peptide-based nanomaterials in cancer immunotherapy.
  • Analysis of functionalization and self-assembly techniques for peptide-nanomaterial conjugates.
  • Exploration of machine learning and other novel strategies for peptide discovery and optimization.

Main Results:

  • Peptide-based nanomaterials demonstrate significant potential for targeted drug delivery in cancer immunotherapy.
  • Functionalization and self-assembly are key approaches to creating effective peptide-nanomaterial systems.
  • Machine learning accelerates the identification and design of peptides for therapeutic applications.

Conclusions:

  • Peptide-based nanomaterials represent a promising frontier in the development of next-generation tumor immunotherapies.
  • Integration of advanced screening technologies like machine learning will drive innovation in peptide-based cancer treatments.
  • Further research into these platforms could lead to more effective and personalized cancer therapies with reduced side effects.